8. June 2022

from von Rainer Krüger und Dr. Lisann Eßer, J&K Consulting High demand and supposedly large profits are bringing more and more manufacturers of cannabis medicines onto the market. But can the products on offer provide the required quality? Since cannabis is to be sold in Germany as a pharmaceutical product, its production is regulated by the German Medicines Act and the Good Manufacturing Practice (GMP) guidelines. The guidelines aim to ensure the production of pharmaceutical products of consistent and high quality. However, product recalls in Canada are…

from von Rainer Krüger und Dr. Lisann Eßer, J&K Consulting The prescription of medicinal cannabis in Germany has been rising constantly in the last few years, which means that both the demand and the market are growing equally. However, medicinal cannabis is a drug whose active ingredient composition and concentration depend on the genetics of the plant and thus also achieve a different effect on the patient based on the genetics. By sequencing the genomes and comparing the sequences of…